Gene Therapy Development & Manufacturing Services

Accelerate your gene therapy development with Pharmaron’s end-to-end manufacturing and analytical solutions. With over 15 years of expertise and a track record of successful late-phase programs, our Liverpool-based CDMO delivers scalable, high-quality production to support preclinical through clinical-stage development.

Key highlights from this service overview include:

• Comprehensive Development Services: From plasmid design and cell line development to GMP production and QP release, we provide a fully integrated approach.
• State-of-the-Art Manufacturing: Scalable suspension-based AAV production, single-use technologies, and chromatography-based purification ensure efficiency and quality.
• Regulatory & Analytical Expertise: MHRA-licensed GMP suites, best-in-class product characterization, and CMC dossier authoring support global regulatory submissions.

With flexible production scales (15mL to 500L bioreactors) and a proven platform process, Pharmaron is your trusted partner in delivering next-generation gene therapies.

Download the service overview to explore how we can support your development pipeline.